Skip to main content

Time for Advance Care Planning Discussions During Transitions in Care in Cancer Clinical Trials

In a JAMA Oncology viewpoint, Connie Ulrich and Christine Grady, discuss the importance of safe transitions in care when patients leave a clinical trial voluntarily or involuntarily.